About Jonathan Leinonen
Form D filings for Stabilux Biosciences in 2024 list Jonathan Leinonen as executive officer and director.
Jonathan Leinonen first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Jonathan Leinonen in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jonathan Leinonen works with at each company, as listed on that company's latest Form D.
Stabilux Biosciences, Inc. · Form D, May 16, 2024
YY
Yoke Yap
President and director
MM
Michael Mortlock
Executive officer
ME
Mark Ehlert
Director
ST
Steve Tokarz
Executive officer and director
JR
John Ransom
Director